BCL2 and breast carcinoma: However in human breast cancer, it was proven in different studies that Bcl-2 expression is associated with a favorable outcome [2, 5] in terms of disease-free interval [6–10], overall survival [6, 8, 10–13] and specific survival [7, 14].